• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用力呼气量(FEV)和气流受限对运动时呼吸困难和腿部用力强度的影响。来自真实世界队列的见解。

The contribution of FEV and airflow limitation on the intensity of dyspnea and leg effort during exercise. Insights from a real-world cohort.

机构信息

Division of Respirology, Department of Medicine, McMaster University, Hamilton, ON, Canada.

Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, ON, Canada.

出版信息

Physiol Rep. 2020 Apr;8(8):e14415. doi: 10.14814/phy2.14415.

DOI:10.14814/phy2.14415
PMID:32323482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7177171/
Abstract

RATIONALE

The effort required to cycle and breathe intensify as power increases during incremental exercise. It is currently unclear how changes in FEV in the presence or absence of airflow limitation) impacts the intensity of dyspnea and leg effort. This is clinically important as the improvement in FEV is often the target for improving dyspnea.

OBJECTIVES

To investigate the relationship between dyspnea (D), leg effort, power (P), and FEV with and without airflow limitation using direct psychophysical scaling performed during incremental exercise testing to symptom limited capacity.

METHODS

Retrospective analysis of consecutive patients over the age of 35 referred for cardio-pulmonary exercise testing at McMaster University Medical Centre from 1988-2012.The modified Borg scale was used to measure dyspnea throughout incremental exercise testing.

MEASUREMENTS AND RESULTS

38,788 patients were included in the analysis [Mean Age 58.6 years (SD ±11.8), Males 61%, BMI 28.1 kg/m (SD ±5.1), FEV was 2.7 L (SD ±0.85), 95% predicted (SD ±20.4), FVC 3.4 L (SD ± 1.0), 94% predicted (SD ±17.0)], and 10.9% had airflow limitation (AL, FEV /FVC < 70%). In a nonlinear regression analysis, the intensity of dyspnea increased in a positively accelerating manner with power and as the FEV % predicted decreased: Dyspnea = 0.06 * Power  * FEV %Pred (r = .63). The intensity of leg effort increased with power and declining quadricep strength and FEV1% predicted: Leg Effort = 0.06 * Power * Quad *FEV %Pred (r = .73). There was no independent effect of AL on dyspnea of leg effort.

CONCLUSION

Power, quadriceps strength and FEV1 are the dominant factors contributing to dyspnea and leg effort, irrespective of the degree of airflow limitation.

摘要

原理

在递增运动过程中,随着功率的增加,骑行和呼吸所需的努力也会增加。目前尚不清楚在存在或不存在气流受限的情况下,FEV 的变化如何影响呼吸困难和腿部用力的强度。这在临床上很重要,因为改善 FEV 通常是改善呼吸困难的目标。

目的

使用递增运动测试至症状限制能力时直接进行心理物理标度来研究在存在或不存在气流受限的情况下,呼吸困难 (D)、腿部用力、功率 (P) 和 FEV 之间的关系。

方法

对 1988 年至 2012 年期间在麦克马斯特大学医学中心进行心肺运动测试的年龄在 35 岁以上的连续患者进行回顾性分析。整个递增运动测试过程中使用改良的 Borg 量表来测量呼吸困难。

测量和结果

38788 例患者纳入分析[平均年龄 58.6 岁(SD ±11.8),男性 61%,BMI 28.1kg/m(SD ±5.1),FEV 为 2.7L(SD ±0.85),95%预计值(SD ±20.4),FVC 为 3.4L(SD ±1.0),94%预计值(SD ±17.0)],10.9%存在气流受限(AL,FEV/FVC<70%)。在非线性回归分析中,呼吸困难的强度以正加速的方式随功率增加而增加,随着 FEV 预计值的降低而增加:呼吸困难=0.06功率FEV 预计值(r=.63)。腿部用力的强度随功率增加而增加,随着股四头肌力量和 FEV1 预计值的下降而增加:腿部用力=0.06功率股四头肌*FEV 预计值(r=.73)。AL 对呼吸困难和腿部用力没有独立影响。

结论

功率、股四头肌力量和 FEV1 是导致呼吸困难和腿部用力的主要因素,与气流受限的程度无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e3/7177171/5deca6f8a6b1/PHY2-8-e14415-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e3/7177171/fef2863b44e4/PHY2-8-e14415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e3/7177171/b15647b9d1e4/PHY2-8-e14415-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e3/7177171/5deca6f8a6b1/PHY2-8-e14415-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e3/7177171/fef2863b44e4/PHY2-8-e14415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e3/7177171/b15647b9d1e4/PHY2-8-e14415-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e3/7177171/5deca6f8a6b1/PHY2-8-e14415-g003.jpg

相似文献

1
The contribution of FEV and airflow limitation on the intensity of dyspnea and leg effort during exercise. Insights from a real-world cohort.用力呼气量(FEV)和气流受限对运动时呼吸困难和腿部用力强度的影响。来自真实世界队列的见解。
Physiol Rep. 2020 Apr;8(8):e14415. doi: 10.14814/phy2.14415.
2
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
3
Symptom intensity and subjective limitation to exercise in patients with cardiorespiratory disorders.心肺疾病患者的症状强度及运动的主观受限情况
Chest. 1996 Nov;110(5):1255-63. doi: 10.1378/chest.110.5.1255.
4
Exercise-induced bronchoconstriction and bronchodilation: investigating the effects of age, sex, airflow limitation and FEV.运动诱发性支气管收缩和支气管舒张:研究年龄、性别、气流受限和 FEV 的影响。
Eur Respir J. 2021 Aug 26;58(2). doi: 10.1183/13993003.04026-2020. Print 2021 Aug.
5
Preliminary investigation of cardiopulmonary function in stroke patients with stable heart failure and exertional dyspnea.稳定型心力衰竭和劳力性呼吸困难的中风患者心肺功能的初步调查
Medicine (Baltimore). 2016 Oct;95(40):e5071. doi: 10.1097/MD.0000000000005071.
6
Abnormal Exertional Breathlessness on Cardiopulmonary Cycle Exercise Testing in Relation to Self-Reported and Physiologic Responses in Chronic Airflow Limitation.慢性气流受限患者心肺循环运动试验中自觉用力呼吸困难与生理反应的关系
Chest. 2024 Jul;166(1):81-94. doi: 10.1016/j.chest.2024.02.034. Epub 2024 Feb 27.
7
Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation.
Am Rev Respir Dis. 1992 Oct;146(4):935-40. doi: 10.1164/ajrccm/146.4.935.
8
Low resting diffusion capacity, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者静息时弥散功能降低、呼吸困难和运动耐量下降。
J Appl Physiol (1985). 2019 Oct 1;127(4):1107-1116. doi: 10.1152/japplphysiol.00341.2019. Epub 2019 Aug 1.
9
The relationship between exercise capacity and different functional markers in pulmonary rehabilitation for COPD.慢性阻塞性肺疾病(COPD)肺康复中运动能力与不同功能标志物之间的关系。
Int J Chron Obstruct Pulmon Dis. 2018 Feb 28;13:717-724. doi: 10.2147/COPD.S153525. eCollection 2018.
10
Dyspnea, effort and muscle pain during exercise in lung transplant recipients: an analysis of their association with cardiopulmonary function parameters using machine learning.肺移植受者运动时的呼吸困难、用力和肌肉疼痛:使用机器学习分析其与心肺功能参数的关系。
Respir Res. 2020 Oct 15;21(1):267. doi: 10.1186/s12931-020-01535-5.

引用本文的文献

1
Respiratory burden in post-acute COVID-19 sequelae: a longitudinal study of airway and systemic inflammation and clinical outcomes.新冠后急性后遗症中的呼吸负担:气道与全身炎症及临床结局的纵向研究
ERJ Open Res. 2025 Jun 23;11(3). doi: 10.1183/23120541.01331-2024. eCollection 2025 May.
2
Investigation of respiratory muscle strength and its influence on exercise capacity and quality of life in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者呼吸肌力量及其对运动能力和生活质量影响的研究。
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Jun 28;41(2):e2024028. doi: 10.36141/svdld.v41i2.14884.
3
The added value of haemoglobin to height, age, and sex to predict DLCO in subjects with preserved exercise capacity.

本文引用的文献

1
Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness tiotropium alone in COPD.噻托溴铵/奥达特罗双重支气管扩张作用进一步减轻 COPD 患者的活动相关呼吸困难,优于单用噻托溴铵。
Eur Respir J. 2019 Mar 28;53(3). doi: 10.1183/13993003.02049-2018. Print 2019 Mar.
2
Effect of Bronchodilation, Exercise Training, and Behavior Modification on Symptoms and Physical Activity in Chronic Obstructive Pulmonary Disease.支气管扩张、运动训练和行为改变对慢性阻塞性肺疾病症状和身体活动的影响。
Am J Respir Crit Care Med. 2018 Oct 15;198(8):1021-1032. doi: 10.1164/rccm.201706-1288OC.
3
Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis.
血红蛋白对身高、年龄和性别在预测运动能力正常者 DLCO 中的附加价值。
PLoS One. 2023 Aug 8;18(8):e0289540. doi: 10.1371/journal.pone.0289540. eCollection 2023.
4
Reference equations for breathlessness during incremental cycle exercise testing.递增式自行车运动试验中呼吸困难的参考方程。
ERJ Open Res. 2023 Apr 11;9(2). doi: 10.1183/23120541.00566-2022. eCollection 2023 Mar.
5
Eight Weeks of Supervised Pulmonary Rehabilitation Are Effective in Improving Resting Heart Rate and Heart Rate Recovery in Severe COVID-19 Patient Survivors of Mechanical Ventilation.八周的监督性肺康复可有效改善机械通气的重症 COVID-19 患者幸存者的静息心率和心率恢复。
Medicina (Kaunas). 2022 Apr 5;58(4):514. doi: 10.3390/medicina58040514.
6
Does Regular Physical Activity Mitigate the Age-Associated Decline in Pulmonary Function?经常进行身体活动能减轻与年龄相关的肺功能下降吗?
Sports Med. 2022 May;52(5):963-970. doi: 10.1007/s40279-022-01652-9. Epub 2022 Feb 3.
噻托溴铵和奥达特罗治疗 COPD 的疗效和安全性:系统评价和荟萃分析。
Respir Res. 2017 Nov 25;18(1):196. doi: 10.1186/s12931-017-0683-x.
4
Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis.长效β2受体激动剂/长效抗胆碱能药物联合使用对慢性阻塞性肺疾病运动耐力和肺过度充气的影响:一项成对和网状荟萃分析。
Respir Med. 2017 Aug;129:189-198. doi: 10.1016/j.rmed.2017.06.020. Epub 2017 Jun 29.
5
Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD.噻托溴铵/奥达特罗联合用药对慢性阻塞性肺疾病吸气容量和运动耐力的影响。
Eur Respir J. 2017 Apr 19;49(4). doi: 10.1183/13993003.01348-2016. Print 2017 Apr.
6
Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial.慢阻肺病中乌美溴铵/维兰特罗与丙酸氟替卡松/沙美特罗的对比:一项随机试验
BMC Pulm Med. 2015 Aug 19;15:91. doi: 10.1186/s12890-015-0092-1.
7
Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study.QVA149 双重支气管扩张与单一支气管扩张剂治疗的比较:SHINE 研究。
Eur Respir J. 2013 Dec;42(6):1484-94. doi: 10.1183/09031936.00200212. Epub 2013 May 30.
8
Prognostic value of the objective measurement of daily physical activity in patients with COPD.客观测量 COPD 患者日常体力活动的预后价值。
Chest. 2012 Aug;142(2):338-346. doi: 10.1378/chest.11-2014.
9
Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis.肺功能变化与慢性阻塞性肺疾病患者结局的相关性:一项汇总分析。
Respir Res. 2011 Dec 29;12(1):161. doi: 10.1186/1465-9921-12-161.
10
Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study.体力活动是 COPD 患者全因死亡率的最强预测因素:一项前瞻性队列研究。
Chest. 2011 Aug;140(2):331-342. doi: 10.1378/chest.10-2521. Epub 2011 Jan 27.